Corcept Therapeutics

Senior Director, Clinical Pharmacology

Corcept Therapeutics • $261K — $307K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • 10-15 years of industry experience in pharmacokinetics or clinical pharmacology
  • PhD, PharmD, or MD degree with a focus in relevant fields
  • In-depth knowledge of data analysis software (e.g., Excel, NONMEM, R)
  • Thorough understanding of regulatory requirements
  • Excellent written and oral communication skills
  • Proven problem-solving and leadership abilities

Responsibilities

  • Contribute to and implement clinical pharmacology development strategies
  • Design and oversee complex clinical pharmacology studies
  • Serve as departmental representative on project teams
  • Provide subject matter expertise in cross-functional collaborations
  • Adhere to timelines for prompt execution of deliverables
  • Analyze and report nonclinical and clinical data
  • Manage and mentor direct and indirect reports

Benefits

  • Hybrid work model with on-site presence required at least three days a week
  • Opportunity to lead a small internal team
  • Engagement in innovative drug development processes
  • Collaboration with senior leaders and cross-functional teams
  • Involvement in regulatory interactions and submissions
Full Job Description
The Senior Director of Clinical Pharmacology contributes to the design and execution of the Clinical Pharmacology Development strategy for our small-molecule pipeline, and serves as a scientific bridge between research and development. This role will work closely with the Vice President of Clinical Pharmacology and Pharmacokinetics to develop pharmacokinetic and/or pharmacometric strategies to accelerate and support the overall product development, including securing drug approvals as well as advancing lead compounds into humans.

Corcept operates a lean research and development model. The Senior Director of Clinical Pharmacology will lead a small internal team while also having individual contributor responsibilities. This is a hybrid role based at our Redwood City, California headquarters, typically requiring on-site presence at least three days per week.

Responsibilities:
  • Contributing to and implementing a comprehensive clinical pharmacology development strategy for our investigational compounds
  • Designing and overseeing complex clinical pharmacology studies and/or assessments in healthy volunteers and in patients
  • Serving as the departmental representative on project teams supporting nonclinical and clinical development
  • Providing subject matter expertise in cross functional teams and collaborating with other team members
  • Strictly adhering to agreed timelines to ensure prompt and accurate execution of deliverables
  • Analyzing, interpreting, and reporting nonclinical and clinical data
  • Plotting and evaluating animal and human pharmacokinetic data
  • Reviewing and approving pharmacokinetic and/or toxicokinetic reports
  • Reviewing and approving bioanalytical and method validation reports
  • Understanding, establishing, and integrating innovative tools and technologies to accelerate drug development
  • Authoring and owning the pharmacokinetic-related content of Investigator Brochures, study protocols, analysis plans, bioanalytical reports, and study reports
  • Authoring, leading, and owning nonclinical and clinical pharmacokinetic-related documents for regulatory submissions, including INDs, NDAs, MAAs etc
  • Supporting global regulatory interactions including preparing for and/or attending formal regulatory meetings, and responding to questions/requests from regulators
  • Managing and mentoring direct and indirect reports
  • Overseeing and managing vendors and consultants

Preferred Skills, Qualifications and Technical Proficiencies:
  • Hands-on and in-depth knowledge of current versions of data analysis software such as Excel, GraphPad, WinNonlin, Monolix, NONMEM, R and/or other pharmacokinetic/pharmacometrics tools
  • Hands-on and in-depth knowledge of current versions of PowerPoint and Word etc
  • Thorough understanding of current regulatory requirements
  • Excellent written and oral communication skills
  • Proven ability to critically analyze problems, provide creative solutions, and influence senior leaders
  • Discipline and confidence to work in teams and to work independently

Preferred Education and Experience:
  • 10-15 or more years of industry experience and a PhD, PharmD or MD degree with emphasis in pharmacokinetics, clinical pharmacology, or a related field

The pay range that the Company reasonably expects to pay for this headquarters-based position is $261,400 - $307,600; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link.

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

Please visit our website at: https://www.corcept.com/

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.

About Corcept Therapeutics

Corcept Therapeutics is a commercial-stage pharmaceutical company engaged in the discovery and development of drugs for the treatment of severe metabolic, oncologic and psychiatric disorders. The company's lead product, Korlym, is a cortisol receptor blocker that modulates the effects of cortisol, a hormone produced by the adrenal gland. Korlym is approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with Cushing's syndrome who have type 2 diabetes or glucose intolerance. The company is also developing other cortisol modulators, including CORT125134, which is in Phase II clinical trials for the treatment of patients with Cushing's syndrome and solid-tumor cancers. Corcept Therapeutics was founded in 1998 and is headquartered in Menlo Park, California.
Learn more about Corcept Therapeutics
Size
238 employees
Market Cap
$2.1 billion
Industry
Net Income
$106 million
Founded
1998
5 Year Trend
+35.1%
Revenue
$353.8 million
NASDAQ

Similar Jobs

More Jobs at Corcept Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Senior Director, Clinical Pharmacology jobs: